Ignite Creation Date:
2025-12-25 @ 5:18 AM
Ignite Modification Date:
2026-02-25 @ 4:05 AM
Study NCT ID:
NCT02090127
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2015-07-29
First Post:
2014-03-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
Sponsor:
AVEO Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2014-03-14
First Submit QC Date:
None
Study First Post Date:
2014-03-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-27
Last Update Post Date:
2015-07-29
Last Update Post Date Type:
ESTIMATED